Obstructive Sleep Apnea Clinical Trial
Official title:
An Interventional Open Feasibility Sleep Study to Determine Effectiveness of StimAire's Injectable and Wearable Neurostimulator in Participants With Obstructive Sleep Apnea
Verified date | April 2024 |
Source | StimAire Australia Pty Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The StimAire Model S is intended to treat Obstructive Sleep Apnea (OSA) by stimulating the hypoglossal nerve. The system includes a dedicated neurostimulator and a breathing sensor. The system is to be used in participants diagnosed with moderate to severe Obstructive Sleep Apnea. The Sponsor will be evaluating the change in Apnea-Hypopnea Index (AHI) when using the StimAire Model S system.
Status | Terminated |
Enrollment | 7 |
Est. completion date | April 12, 2023 |
Est. primary completion date | April 12, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Obstructive Sleep Apnea (defined by AHI > 15 and < 50 per hour of sleep with non-supine AHI>10; with hypopneas defined as greater than 30% reduction in airflow with 3% or greater drop in oxygen saturation). AHI will be determined by full night polysomnography as per guidelines of the American Academy of Sleep Medicine. 2. Age range > 18 years. 3. Difficulty accepting or adhering to, or not desiring of, CPAP therapy. 4. Participant has willingly consented to participate in the study. 5. Participant is willing to remove or have removed facial hair between the base of the neck and the mandible. Exclusion Criteria: 1. Body mass index > 32 kg/m2. Obese individuals are less responsive to OSA neurostimulation. 2. Documented central or complex sleep apnea > 5 per hour. 3. Participants with pacemaker, defibrillator, or implanted neurostimulators. 4. Hypoxemic and requiring oxygen supplementation. 5. Prior diagnosis of Decompensated cardiac (heart failure [New York heart Association Category III or IV]; or angina) or pulmonary (severe COPD or uncontrolled asthma) disease. 6. Prior diagnosis of any moderate to severe pulmonary artery hypertension. 7. Diagnosis of another sleep disorder in addition to OSA based on PSG (e.g., periodic limb movement arousal index > 10, insomnia, obesity hypoventilation syndrome, or narcolepsy). 8. Hypoglossal nerve palsy on either hypoglossal nerve. 9. Prior diagnosis of neuromuscular disease. 10. Recent or recurring history of recreational drug use leading to tolerance or dependence, at the discretion of the investigators 11. Prior diagnosis of persistent uncontrolled hypertension despite antihypertensive medication use. 12. Any unstable medical or psychiatric comorbidity at the discretion of the investigators 13. Actively taking anticoagulation medication 14. Aspirin taken within 2 weeks prior to injection at the discretion of the investigators 15. Bilateral or unilateral pathology in the submandibular space 16. Actively participating in another clinical trial that to the investigators opinion may compromise this study results. 17. Hypoglossal nerve depth greater than 2.5 cm at the target location of the stimulating electrode as observed on ultrasound display. 18. Tonsil size of 3 or 4 (tonsils visible beyond the pillars or extending to midline) or another anatomical obstruction, at the discretion of the investigators 19. The participant is not appropriate for the regimen for another reason, at the discretion of the investigators |
Country | Name | City | State |
---|---|---|---|
Australia | Sleep & Breathing Specialist Centre | Sydney | New South Wales |
Lead Sponsor | Collaborator |
---|---|
StimAire Australia Pty Ltd |
Australia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Percent of successful placements of device | Number of successful placements of the device | Up to 15 Months | |
Primary | Change in AHI | Number of apnea or hypopnea events per hour represented by AHI score | Up to 15 Months | |
Secondary | Change in AHI from baseline for stimulation synchronized with inhalation compared to change in AHI for unsynchronized stimulation | Number of apnea or hypopnea events per hour represented by AHI score | Up to 15 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |